Morgan Stanley Ice Cure Medical Ltd. Put Options Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ICCM
# of Institutions
19Shares Held
250KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il52.5KShares$43,5940.0% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$33,5750.0% of portfolio
-
Two Sigma Securities, LLC New York, NY25.3KShares$21,0370.0% of portfolio
-
Gunderson Capital Management Inc.20KShares$16,6000.01% of portfolio
-
Lpl Financial LLC Fort Mill, SC18.9KShares$15,6660.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $30.6M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.